AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 36 filers reported holding AUTOLUS THERAPEUTICS PLC in Q1 2019. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,032,000 | +10.0% | 78,168 | +3.5% | 0.00% | 0.0% |
| Q3 2019 | $938,000 | +7.0% | 75,551 | +38.7% | 0.00% | 0.0% |
| Q2 2019 | $877,000 | -43.4% | 54,455 | +10.5% | 0.00% | -50.0% |
| Q1 2019 | $1,550,000 | -4.2% | 49,260 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $1,618,000 | +14.3% | 49,260 | +4.9% | 0.00% | +33.3% |
| Q3 2018 | $1,416,000 | – | 46,947 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TFG Asset Management GP Ltd | 1,300,000 | $17,160,000 | 2.55% |
| Alphabet Inc. | 699,352 | $9,231,000 | 0.56% |
| DAFNA Capital Management LLC | 100,000 | $1,320,000 | 0.45% |
| JUPITER ASSET MANAGEMENT LTD | 705,356 | $9,311,000 | 0.29% |
| Artal Group S.A. | 500,000 | $6,600,000 | 0.26% |
| Cormorant Asset Management, LP | 479,988 | $6,336,000 | 0.25% |
| MPM BioImpact LLC | 39,740 | $525,000 | 0.19% |
| Granahan Investment Management | 305,158 | $4,028,000 | 0.18% |
| Burrage Capital Management LLC | 13,113 | $173,000 | 0.12% |
| Vident Investment Advisory, LLC | 118,866 | $1,569,000 | 0.10% |